Good news! Pfizer’s corona vaccine is 90% effective in late-stage trials

Nov. 10, 2020, 3:50 p.m.

NEW DELHI (DIVYA SAINI): There is great news for the world that is suffering from Corona virus Pandemic. The Corona Vaccine of the company Pfizer has been found to be 90% effective in the clinical trial and has proved even better than expected. Not only this, if everything goes well, by the end of this month, the company can get approval to sell the vaccine. This is certainly very hopeful news to prevent the global pandemic. Pfizer is making Corona’s vaccine with its partner BioNTech. Pfizer is American company whereas BioNTech is German company.

The company said on Monday that during its vaccine trial, 90% of 94 infected were found to be effective. Among these infected, there was at least 1 symptom of COVID-19. The vaccine is still in the trial phase, but the results are hoping that soon the path of its use can be cleared worldwide. 

The company said the results showed that it was successful in preventing the disease in volunteers who tested it. If the rest of the data also indicates that the vaccine is safe, the company will apply for permission to sell the vaccine from Health Regulators before the end of this month.

Pfizer said that so far no serious safety issues have been revealed during the clinical trials. The trial is done on about 44,000 people in the US and other countries. However, it is not yet clear how long the vaccine will develop immunity against people in the corona.

READ ALSO :  Third eye: Expenditure on Central Vista attracts criticism

The company has reviewed the vaccine trials from a panel of external experts to ensure that the results are accurate and the process is completely transparent. The panel is known as the Data Safety Monitoring Committee which finds out how effective and safe the vaccine candidate is. The panel has shared the results of its review with Pfizer and BioNTech.

Source link

Leave a Comment